Skip to main content
OpenTrials

Clinical trial condition

Generalized Pustular Psoriasis

Explore clinical trials studying Generalized Pustular Psoriasis. Study availability and eligibility vary by location and protocol.

19 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Generalized Pustular Psoriasis trial results

Completed

A Study to Test Whether BI 655130 (Spesolimab) Prevents Flare-ups in Patients With Generalized Pustular Psoriasis

NCT04399837

Conditions
Generalized Pustular Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • Oakland Hills Dermatology Auburn Hills, Michigan, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Buenos Aires Skin S.A. CABA, Argentina
  • Hospital Italiano de Buenos Aires CABA, Argentina
View all 72 locations
View Trial Details
Completed

Effisayil™ 1: A Study to Test Spesolimab (BI 655130) in Patients With a Flare-up of a Skin Disease Called Generalized Pustular Psoriasis

NCT03782792

Conditions
Generalized Pustular Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Miami Miami, Florida, United States
  • University of South Florida Tampa, Florida, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
View all 37 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Generalized Pustular Psoriasis

NCT03619902

Conditions
Generalized Pustular Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • Site 102 Encino, California, United States
  • Site 105 Largo, Florida, United States
  • Site 104 Miami, Florida, United States
  • Site 101 Indianapolis, Indiana, United States
View all 13 locations
View Trial Details
Completed

An Expanded Access Trial in Japan to Provide Spesolimab to People With a Flare-up in Generalized Pustular Psoriasis Who Have no Other Treatment Options

NCT05200247

Conditions
Generalized Pustular Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • Nagoya City University Hospital Aichi, Nagoya, Japan
  • Fukuoka University Hospital Fukuoka, Fukuoka, Japan
  • Kagoshima University Hospital Kagoshima, Kagoshima, Japan
  • Mie University Hospital Mie, Tsu, Japan
View Trial Details
Completed

A Study of Ixekizumab (LY2439821) in Participants in Japan With Generalized Pustular Psoriasis and Erythrodermic Psoriasis

NCT03942042

Conditions
Erythrodermic Psoriasis, Generalized Pustular Psoriasis, Psoriasis, +3 more
Locations
  • Nagoya City University Hospital Nagoya, Aichi-ken, Japan
  • Tohoku University Hospital Sendai, Miyagi, Japan
  • Kansai Medical University Hospital Hirakata, Osaka, Japan
  • Teikyo University Hospital Itabashi-ku, Tokyo, Japan
View Trial Details
Terminated

A Clinical Trial of TQH2929 Injection in Patients With Acute Flare-up of Generalized Pustular Psoriasis

NCT07314060

Conditions
Generalized Pustular Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • Peking University First Hospita Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China
  • Southern Medical University Dermatology Hospital Guangzhou, Guangdong, China
View all 31 locations
View Trial Details

Related conditions